The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing

被引：11

作者：

Hu, Tianyan ^{[1
]}

Decker, Sandra L. ^{[2
]}

Chou, Shin-Yi ^{[3
]}

机构：

[1] Florida Int Univ, Dept Hlth Policy & Management, AHC5-452,11200 SW 8th St, Miami, FL 33199 USA

[2] AHRQ, 540 Gaither Rd, Rockville, MD 20850 USA

[3] Lehigh Univ, Dept Econ, 621 Taylor St, Bethlehem, PA 18015 USA

来源：

INTERNATIONAL JOURNAL OF HEALTH ECONOMICS AND MANAGEMENT | 2017年 / 17卷 / 03期

关键词：

Medicare; Part D; Prescription drug; Expenditure of health care; Prescribing pattern; REGRESSION DISCONTINUITY DESIGNS; PRESCRIPTION DRUG-USE; PHARMACEUTICAL PRICES; CARE; SERVICES; COSTS; ECONOMICS; QUALITY;

D O I：

10.1007/s10754-017-9211-2

中图分类号：

F8 [财政、金融];

学科分类号：

0202 ;

摘要：

We test the effect of the introduction of Medicare Part D on physician prescribing behavior by using data on physician visits from the National Ambulatory Medical Care Survey (NAMCS) 2002-2004 and 2006-2009 for patients aged 60-69. We use regression discontinuity designs to estimate the effect of part D around the age of 65 before and after 2006 and then compare the discrete jump in outcomes at age 65 before and after Part D. We find a 32% increase in the number of prescription drugs prescribed or continued per visit and a 46% increase in the number of generic drugs prescribed or continued for the elderly after the introduction of Medicare Part D.

引用

页码：333 / 358

页数：26

共 50 条

[31] Visualizing nationwide variation in medicare Part D prescribing patterns
Alexander Rosenberg
Christopher Fucile
Robert J. White
Melissa Trayhan
Samir Farooq
Caroline M. Quill
Lisa A. Nelson
Samuel J. Weisenthal
Kristen Bush
Martin S. Zand
BMC Medical Informatics and Decision Making, 18
[32] Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures
Donohue, Julie M.
Normand, Sharon-Lise T.
Horvitz-Lennon, Marcela
Men, Aiju
Berndt, Ernst R.
Huskamp, Haiden A.
JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2016, 19 (02) : 69 - 78
[33] The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
Carvalho, Natalie
Petrie, Dennis
Chen, Linkun
Salomon, Joshua A.
Clarke, Philip
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2019, 18 (1)
[34] Changes in Physician Electronic Health Record Use With the Expansion of Telemedicine
Holmgren, A. Jay
Thombley, Robert
Sinsky, Christine A.
Adler-Milstein, Julia
JAMA INTERNAL MEDICINE, 2023, 183 (12) : 1357 - 1365
[35] Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending
Briesacher, BA
Stuart, B
Ren, XQ
Doshi, JA
Wrobel, MV
HEALTH SERVICES RESEARCH, 2005, 40 (05) : 1279 - 1296
[36] Medicare Physician Payment Systems: Impact of 2011 Schedule on Interventional Pain Management
Manchikanti, Laxmaiah
Singh, Vijay
Caraway, David L.
Benyamin, Ramsin M.
Hirsch, Joshua A.
PAIN PHYSICIAN, 2011, 14 (01) : E5 - E33
[37] Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D
Strickland, Justin C.
Huhn, Andrew S.
Bergeria, Cecilia L.
Strain, Eric C.
Dunn, Kelly E.
JOURNAL OF ADDICTION MEDICINE, 2021, 15 (04) : 325 - 333
[38] Differential Effects by Mental Health Status of Filling the Medicare Part D Coverage Gap
Liu, Judith
Zhang, Yuting
Kaplan, Cameron M.
MEDICAL CARE, 2022, 60 (02) : 133 - 139
[39] The Impact of Medicare Part D on Hospitalization Rates
Afendulis, Christopher C.
He, Yulei
Zaslavsky, Alan M.
Chernew, Michael E.
HEALTH SERVICES RESEARCH, 2011, 46 (04) : 1022 - 1038
[40] Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D
Kaestner, Robert
Schiman, Cuping
Alexander, G. Caleb
JOURNAL OF RISK AND INSURANCE, 2019, 86 (03) : 595 - 628

← 1 2 3 4 5 →